Overview
- Verily, Alphabet’s health-research unit, has asked the Environmental Protection Agency for an Experimental Use Permit to release up to 32 million male Wolbachia‑infected Aedes aegypti mosquitoes per year in Florida and California, a proposal reported widely on Tuesday.
- Wolbachia is a naturally occurring bacterium that causes eggs from matings between treated males and wild females to fail to hatch, and the Debug project says only males would be released because males do not bite people.
- The company plans to use automated rearing, computer vision and AI-driven sex-sorting to mass-produce and identify males and to reduce the chance that females are released.
- The filing has prompted public alarm and political criticism over corporate involvement and ecological risk, with some elected officials and online groups demanding stricter oversight and local consent.
- Similar Wolbachia or lab-bred mosquito programs have been trialed since 2021 with evidence of local mosquito declines and reduced disease risk in some places, and the EPA’s decision will determine required safeguards, monitoring and community engagement for any U.S. rollout.